[Treatment of cardiac insufficiency with beta-methyldigoxin and the clinical significance of the blood concentration of digitalis glycosides].
D000328:Adult; D000368:Aged; D001702:Biopharmaceutics; D002908:Chronic Disease; D003327:Coronary Disease / Q000188:drug therapy*; D004071:Digitalis Glycosides / Q000097:blood*; D004077:Digoxin / Q000031:analogs & derivatives* / Q000097:blood / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D005260:Female; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012214:Rheumatic Heart Disease / Q000188:drug therapy*
D004071:Digitalis Glycosides; D004077:Digoxin
Lechenie na surdechnata nedostatuchnost s beta-metil-digoksin i klinichno znachenie na kruvnata kontsentratsiia na digitalisovite gliukozidi.